News Details

Nov 29, 2022
Next Day Disclosure Return | Next Day Disclosure Returns    read more...
Nov 22, 2022
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section | Announcements and Notices    read more...
Nov 22, 2022
VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING RECENT BUSINESS DEVELOPMENTS | Announcements and Notices    read more...
Nov 22, 2022
BeiGene to Present Final PFS Results from ALPINE Trial Demonstrating Superior PFS for BRUKINSA® Versus IMBRUVICA® in Late-Breaking Oral Session at ASH 2022 | RegularNews    read more...
Nov 21, 2022
LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION | Announcements and Notices    read more...
Nov 21, 2022
CHANGE OF CO-CHAIR OF SCIENTIFIC ADVISORY COMMITTEE | Announcements and Notices    read more...
Nov 17, 2022
VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING RECENT BUSINESS DEVELOPMENTS | Announcements and Notices    read more...
Nov 17, 2022
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib) for the Treatment of Adults with Chronic Lymphocytic Leukemia (CLL) | RegularNews    read more...
Nov 15, 2022
BeiGene Launches Talk About It Program to Elevate the Importance of Addressing Mental Health during Cancer Care | RegularNews    read more...
Nov 14, 2022
GRANT OF SHARE OPTIONS | Announcements and Notices    read more...
Nov 11, 2022
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section | Announcements and Notices    read more...
Nov 10, 2022
BeiGene Announces Brazil Approvals for BRUKINSA® As a Treatment for Rare Blood Cancers | RegularNews    read more...
Nov 09, 2022
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section | Announcements and Notices    read more...
Nov 09, 2022
OVERSEAS REGULATORY ANNOUNCEMENT - FORM 10-Q | Announcements and Notices    read more...
Nov 09, 2022
INSIDE INFORMATION - UNAUDITED RESULTS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2022 OF BEIGENE, LTD. AND BUSINESS UPDATES | Announcements and Notices    read more...
Nov 09, 2022
BeiGene Reports Third Quarter 2022 Financial Results | RegularNews    read more...
Nov 04, 2022
BeiGene to Present at Upcoming Investor Conferences | RegularNews    read more...
Nov 04, 2022
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022 | Monthly Returns    read more...
Nov 03, 2022
BeiGene to Present Dynamic View of Development Programs for Hematologic Malignancies at 64th ASH Meeting | RegularNews    read more...
Nov 02, 2022
VOLUNTARY ANNOUNCEMENT - UPDATE REGARDING RECENT BUSINESS DEVELOPMENTS | Announcements and Notices    read more...